LSE · Stocky rates: Buy

BONESUPPORT HOLDING AB BONESUPP (0RQO.L)

kr 219.20 ▲ +1.12% as of 24 Aug, 13:28

Stocky turns companies like BONESUPPORT HOLDING AB BONESUPP into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
75
/ 100
Buy

What Stocky thinks

Buy. 0RQO.L scores 90/100 on Growth Compounder metrics, signaling strong revenue expansion and returns on invested capital that justify a growth multiple. Leadership Alignment is moderate (52/100), reflecting mixed insider commitment signals. The critical constraint: Vulnerability Index is elevated due to a thin financial buffer—this company has limited margin for error if growth stalls or macro conditions tighten. Suitable only for investors with conviction in sustained growth.

Compounder Score
90/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
52/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
100/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
48/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for BONESUPPORT HOLDING AB BONESUPP:

75
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 75/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

52
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

100
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

BONESUPPORT HOLDING AB BONESUPP (0RQO.L) — frequently asked

Is BONESUPPORT HOLDING AB BONESUPP (0RQO.L) a good investment right now?

Stocky rates BONESUPPORT HOLDING AB BONESUPP (0RQO.L) at 75/100 — a Hold — quality is solid but valuation or risk factors cap upside. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Buy. 0RQO.L scores 90/100 on Growth Compounder metrics, signaling strong revenue expansion and returns on invested capital that justify a growth multiple. Leadership Alignment is moderate (52/100), reflecting mixed insider commitment signal

What is 0RQO.L's Stocky Verdict?

0RQO.L's current Stocky Verdict is 75/100, placing it in the "Buy" band. This composite combines a 90/100 Compounder score, 52/100 Leadership, Moat rating, and analyst signal.

Does BONESUPPORT HOLDING AB BONESUPP have a competitive moat?

Stocky hasn't finalised a Moat Score for BONESUPPORT HOLDING AB BONESUPP yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is BONESUPPORT HOLDING AB BONESUPP's leadership aligned with shareholders?

BONESUPPORT HOLDING AB BONESUPP scores 52/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to 0RQO.L?

BONESUPPORT HOLDING AB BONESUPP's Vulnerability Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to BONESUPPORT HOLDING AB BONESUPP.

This is just the surface. See the whole picture on BONESUPPORT HOLDING AB BONESUPP.

Sign up free and unlock the full analysis on 0RQO.L — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering 0RQO.L — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for 0RQO.L.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how 0RQO.L changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to 0RQO.L?" · "Is 0RQO.L overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
75
/ 100 · Buy

See BONESUPPORT HOLDING AB BONESUPP the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in 0RQO.L would be worth today.
Practice portfolio
Buy 0RQO.L with virtual money and track it — zero risk.
Free · no real money · learn by doing Open 0RQO.L in Stocky →

Or jump straight to the interactive dashboard for 0RQO.L in the app.